The Management of Drug Submissions Guidance has been revised to include changes resulting from the release of the new Fees in Respect of Drugs and Medical Devices Regulations. Health Canada has indicated that no other revisions were made to the guidance.

The Vancouver Group (IP offices of Australia, Canada and the United Kingdom) and WIPO have launched a pilot system to give their patent examiners access to each other’s search and examination results.